Replies to post #70119 on Cytodyn Inc (CYDY)

[Borel Fields]

The Biospace "Clinical Catch-Up" article (with CytoDyn discussed before Gilead) may have more impact than the Yang interview. Having worked in the industry, I can assure you every business development person in every bio and/or pharma company carefully goes through that site daily.